I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 10 studies | 26% ± 9% | |
| epithelial cell | 3 studies | 22% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 10 studies | 26% ± 9% | |
| epithelial cell | 3 studies | 22% ± 1% |
Insufficient scRNA-seq data for expression of GALNS at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1173.91 | 1445 / 1445 | 100% | 16.06 | 183 / 183 |
| stomach | 100% | 1194.39 | 359 / 359 | 99% | 11.28 | 284 / 286 |
| kidney | 100% | 1674.52 | 89 / 89 | 99% | 14.10 | 893 / 901 |
| lung | 100% | 1944.78 | 578 / 578 | 99% | 14.25 | 1144 / 1155 |
| thymus | 100% | 1970.64 | 653 / 653 | 99% | 9.91 | 599 / 605 |
| intestine | 100% | 1725.49 | 966 / 966 | 99% | 10.42 | 521 / 527 |
| brain | 99% | 1023.02 | 2619 / 2642 | 100% | 9.65 | 703 / 705 |
| breast | 100% | 1253.00 | 459 / 459 | 99% | 11.10 | 1104 / 1118 |
| skin | 100% | 1666.56 | 1809 / 1809 | 98% | 15.66 | 464 / 472 |
| ovary | 100% | 1324.10 | 180 / 180 | 98% | 10.73 | 422 / 430 |
| uterus | 100% | 1613.66 | 170 / 170 | 98% | 12.32 | 449 / 459 |
| bladder | 100% | 1747.24 | 21 / 21 | 97% | 12.06 | 490 / 504 |
| pancreas | 97% | 560.67 | 318 / 328 | 98% | 13.72 | 175 / 178 |
| prostate | 100% | 1936.24 | 245 / 245 | 95% | 8.32 | 477 / 502 |
| adrenal gland | 100% | 1995.39 | 258 / 258 | 94% | 8.96 | 216 / 230 |
| liver | 100% | 966.39 | 226 / 226 | 75% | 5.11 | 304 / 406 |
| adipose | 100% | 1304.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 8.09 | 29 / 29 |
| spleen | 100% | 2059.61 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 9.53 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.81 | 1 / 1 |
| blood vessel | 100% | 1133.92 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 1078.67 | 853 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 1606.27 | 919 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 94% | 7.40 | 75 / 80 |
| muscle | 87% | 462.54 | 696 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0035578 | Cellular component | azurophil granule lumen |
| GO_0043202 | Cellular component | lysosomal lumen |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0043890 | Molecular function | N-acetylgalactosamine-6-sulfatase activity |
| GO_0008484 | Molecular function | sulfuric ester hydrolase activity |
| GO_0004065 | Molecular function | arylsulfatase activity |
| GO_0003943 | Molecular function | N-acetylgalactosamine-4-sulfatase activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | GALNS |
| Protein name | Galactosamine (N-acetyl)-6-sulfatase N-acetylgalactosamine-6-sulfatase N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (GalN6S) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase) N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) GALNS protein |
| Synonyms | DKFZp686M2125 |
| Description | |
| Accessions | ENST00000567525.5 A0A286S6D8 ENST00000569433.1 P34059 A0A7D4WTF4 H3BSU9 H3BNU2 A0A2I6U1L6 ENST00000568311.1 Q96I49 ENST00000568613.5 ENST00000268695.10 A0A7D4WJI5 ENST00000562831.1 H3BP66 Q6MZF5 H3BV24 A0A7D4W8K5 A0A1A7UP97 |
